Committed to Diversity, Equity, and Inclusion

A workplace that works for all.

Our commitment to Diversity, Equity, and Inclusion is essential in our mission to serve patients effectively. We believe that our people's diversity should reflect the communities we serve, enabling us to understand their needs and deliver the best healthcare solutions.

Our Goals

logo1

Achieve gender parity by 2035.

logo2

At least 35% women in senior leadership by 2030.

logo3

Include at least 3% persons with disabilities (PWD) in our workforce by 2030.

Our Initiatives at Dr. Reddy’s Biologics

Striding Toward Equal Women’s Representation

read more

Strengthening Leadership Commitment

read more

Development Initiatives

read more

Responsible to The Planet

Sustainability at the heart of our operations

The next decade presents a great opportunity and a test of our resolve as we journey to meet our
goals. These goals at the heart of our operations are a testament to how harmoniously we strive to
co-exist with all that surrounds us.  

Our Goals

logo1

Achieving 100% renewable power by 2030.

logo2

Becoming water positive by 2025.

logo3

Attaining carbon neutrality in our direct operations (Scope 1 and Scope 2 emissions) by 2030.

logo4

Reducing indirect carbon emissions across our supply chain (Scope 3 emissions) by 12.5% by 2030.

Our Initiatives at Dr. Reddy’s Biologics

Zero Liquid Discharge:

read more

Zero Hazardous Waste to Landfill:

read more

Low Carbon Fuels:

read more

Accreditations and Awards

Dow Jones Sustainability Index
Sustainability Yearbook
Bloomberg GEI

Certifications and Standards

We proudly uphold international standards that ensure quality and safety across our operations:

Prolific in Our Society

Empathy in step with Dr. Anji Reddy’s vision

Giving back to society is a tenet our founder Dr. Anji Reddy instilled in the ethos of our company.
To this end, our community development programme targets four broad areas: Education, Skilling and
Livelihood, Health and Environmental Sustainability.

Our CSR Initiatives

Kallam Anji Reddy Vidyalaya

read more

School Improvement Programme (SIP)

read more

Community Health Intervention Programme (CHIP)

read more

Our News, Stories, and Insights

Development and validation
  • Article
  • 10-09-2022

Development and validation of a specific and sensitive method for detection of anti-tocilizumabantibodies in human serum in presence of high concentrations of drug and target.

  • Article
  • 23-04-2024

Domain specific anti-drug antibody or neutralizing antibody assays? Are they both needed to study the clinical immunogenicity of Abatacept?

  • News
  • 06-02-2025

Dr. Reddy’s enters into collaboration with Henlius for commercialization of HLX15 (daratumumab), a biosimilar candidate to Darzalex & Darzalex Faspro in the U.S., and Europe

  • News
  • 29-06-2024

Zydus and Dr Reddy's ink licensing agreement to co-market Pertuzumab in India.

Hear-From-Us

Hear From Dr. Reddy’s Laboratories

Our shared vision, aspirations, and more.

Bricks of Biologics, appreciates the contribution and celebrates our people who are the building blocks of Dr. Reddy's Biologics.

 

Bricks of biologics in general refers to bio-bricks as genetic building blocks which are DNA sequences that can be assembled to create complex biological systems.